Tactile Medical to Release Fourth Quarter and Fiscal Year 2021 Financial Results on February 22, 2022
Tactile Systems Technology, Inc. (TCMD) will release its fourth quarter and fiscal year 2021 financial results on February 22nd, after market close. A conference call hosted by management is scheduled for 5:00 p.m. ET on the same day, where they will discuss the results and answer questions from participants. Those interested can join the call via telephone or through a live webcast on the company's investor relations website. Tactile Medical focuses on at-home therapies for chronic conditions, aiming to enhance patient care and improve quality of life.
- Focus on expanding access to care for underserved chronic conditions.
- Collaboration with clinicians to enhance clinical evidence and awareness.
- None.
MINNEAPOLIS, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that fourth quarter and fiscal year 2021 financial results will be released after the market closes on Tuesday, February 22nd.
Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on February 22nd to discuss the results of the quarter and the fiscal year. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13726731. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.
For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13726731. The webcast will be archived at investors.tactilemedical.com.
About Tactile Medical
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. The company collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
FAQ
When will Tactile Systems Technology release its fourth quarter 2021 earnings?
What time is the conference call for Tactile Systems Technology's financial results?
How can I access the Tactile Systems Technology conference call?
Will there be a replay of the Tactile Systems Technology conference call?
